BOULDER, Colo., June 7 /PRNewswire-FirstCall/ -- Tapestry Pharmaceuticals, Inc. announced today that management will provide a company update at the 6th Annual Needham & Company Biotechnology and Medical Technology Conference on Wednesday, June 13th, 2007 at 2:00 p.m. EDT. The conference is being held at The New York Palace Hotel in New York City. A live audio webcast of the call will be available on the “Investors” section of the Company’s website, www.tapestrypharma.com. The audio webcast will not be archived.
About Tapestry Pharmaceuticals, Inc.
Tapestry Pharmaceuticals, Inc. is a company focused on the development of proprietary therapies for the treatment of cancer. For more information about Tapestry and its technologies, visit Tapestry’s web site at www.tapestrypharma.com.
Contact: Tapestry Pharmaceuticals, Inc. Gordon Link Senior Vice President, Chief Financial Officer 303-516-8500 glink@tapestrypharma.com Elma Hawkins, Ph.D. Communications and Corporate Development 212-400-3019 ehawkins@tapestrypharma.com Investor: Lilian Stern Stern Investor Relations, Inc. 212-362-1200 lilian@sternir.com Media: Dana Conti Schwartz Communications, Inc. 781-684-0770 tapestry@schwartz-pr.com
Tapestry Pharmaceuticals, Inc.
CONTACT: Gordon Link, Senior Vice President, Chief Financial Officer,+1-303-516-8500, glink@tapestrypharma.com, or Elma Hawkins, Ph.D.,Communications and Corporate Development, +1-212-400-3019,ehawkins@tapestrypharma.com, both of Tapestry Pharmaceuticals, Inc.; orInvestor: Lilian Stern, of Stern Investor Relations, Inc., +1-212-362-1200,lilian@sternir.com; or Media: Dana Conti, of Schwartz Communications, Inc.,+1-781-684-0770, tapestry@schwartz-pr.com, both for TapestryPharmaceuticals, Inc.
Web site: http://www.tapestrypharma.com/
